For researches being conducted with human subjects, the design, conduct, and reporting of
results for the trial should be based on the Clinical Practice guidelines (such as the Good Clinical
Practice in Food and Drug Administration (FDA)-Regulated Clinical Trials (USA) or the
Medical Research Council Guidelines for Good Clinical Practice in Clinical Trials (UK)) and/or
on the World Medical Association (WMA) Declaration of Helsinki.
Any research depicting a study executed with human subjects must affirm through formal
statement that the experiments had the consent (written or verbal, as appropriate) from the
participants before the start of experiment.
Humans: When results of experiments on human subjects need to be reported, authors should
prove the conformance of procedures used with the ethical standards of the responsible
committee on human experimentation (institutional and national) and with the Helsinki
Declaration of 1975, as revised in 2008 (5). If there are any equivocal views about the research’s
conformance with the Helsinki Declaration, the author(s) should highlight the rationale behind
the approach used and prove with evidences that the doubtful aspects of the study have been
approved by the institutional review body.
The content of the website is subject to change. The information on hyper linked or referred to web sites is neither investigated nor analyzed by the Publisher. No warranty or representation, express or implied, is given as to the accuracy or completeness of that information.
For any type of inquiry and support,
you may send an email to
contact@tafpublications.com
Copyright © 2021 TAF Publishing
Calle Alarcon 66, Sant Adrian De Besos 08930, Barcelona Spain | 00 34 610 911 348
.